Pharma Journalist

Pharma Security World 2019 - Anti-Counterfeiting, Drug Serialization and Supply-Chain Security Conference
2019-03-19 - 2019-03-20 | London, United Kingdom
The Counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores. What’s more, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Security World 2019 – Supply-Chain, Drug Serialization and Anti-Counterfeiting Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.

ePharma IMPACT
2019-03-19 - 2019-03-21 | NY Hilton 1335 Ave of the Americas New York, NY 10017, NY, United States
ePharma IMPACT brings together the most influential players across the digital marketing spectrum to reveal truly innovative, next generation omni-channel strategies.
The 3-day event is designed to help you take command of the most influential strategies on the horizon so you can confidently determine where your next digital marketing dollar should be spent for maximum impact.
How do we deliver on that promise? By offering a diversified experience like you won’t find anywhere else. One that translates directly into stronger patient and HCP relationships, and greater influence over impactful marketing strategy.
The 12th annual conference is THE event leading pharma companies rely on to stay ahead of digital disruption and translate digital marketing strategies into bottom line impact.

ProcureCon Pharma 2019
2019-03-19 - 2019-03-20 | Steigenberger Frankfurter Hof, Am Kaiserplatz, Frankfurt/Main, 60311, Germany
Taking place on 19th-20th March 2019 in Frankfurt, ProcureCon Pharma is the only Conference for CPOs & Senior Procurement Executives from leading pharma Companies

Join 150+ senior procurement professionals from Merck, AstraZeneca, Roche, Sanofi, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions, speed up transformation and co-create value with business partners. To learn more about ProcureCon Pharma, download the agenda.
Take away solutions to all of your top challenges:

Master analytical and digital procurement in pharma
Build strategic partnerships with your internal stakeholders
Design and train a high-performing global pharma procurement team
Move beyond savings with key CROS and CMOS to unlock hidden innovation

For more information including the incredible speaker line-up, take a look at the conference brochure here: https://bit.ly/2yIP6a1
Book your place online today: https://bit.ly/2PvKzS8 and get 15% off the current ticket price with our exclusive discount code – “PCPPJ15”

3rd Annual Drug Discovery Chemistry
2019-03-18 - 2019-03-19 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s 3rd Annual Drug Discovery Chemistry
Developing your R&D pipeline with strategies to deliver small molecules
Conference: 18 – 19 March 2019
Workshop: 20 March 2019
Location: Copthorne Tara Hotel, London, UK
Website: www.drug-discovery.co.uk/PJwl
CHAIRED BY:
Roderick Hubbard, Senior Fellow, Vernalis Research Ltd
Darren Green, Director of Molecular Design, GSK
SMi is proud to present its 3rd Annual Drug Discovery Chemistry event, taking place on the 18th-19th March 2019.

The fight to optimise the drug discovery process is on as there is currently a reduced output of new medicines within the market, however, demand for novel drugs is still steadily increasing.M
This year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines, with optimization of the R&D process to become cheaper, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present, as the process is overall long, expensive and often potential drugs will fail late in clinical trials, wasting resources and time.
The event will also focus on novel techniques that can be implemented within the field today that can identify new druggable targets and possibly open new therapeutic areas within the clinic. This could offer opportunities for pharmaceutical companies to produce medicines for diseases and ailments that have previously not been targeted, and likewise, offer new drug targets for existing diseases that could potentially offer better clinical outcomes, such as within the development of cancer drugs.
Drug Discovery Chemistry 2019 will look at various developments within the field, guiding companies on how they can best utilize the newest technologies and drug discovery modalities to develop new medicines, reduce their R&D cost and timelines, and ultimately, increase their medicine output for commercial success.
Event Hashtag: #SMiDrugDisChem
KEY SPEAKERS INCLUDE:

Vivek Vishnudas, Senior Vice President Drug discovery & Platform Sciences, Berg LLC
Tobias Gabriel, Global Head of Discovery Chemistry, Novartis
Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry, Biogen
Hasane Ratni, Expert Scientist, F Hoffmann-La Roche
Alexander Hillisch, Director of Medicinal Chemistry, Bayer

KEY TOPICS FOR 2018 INCLUDE:

Discuss the impact of the use of novel computational techniques on R&D pipelines
Hear about the progress in the development of new drugs on difficult targets and how these can revolutionise patient treatment
Discover how AI is being utilised in the commercial setting and opportunities to best exploit these to streamline the Drug Discovery Process
Explore the potential of new modalities to transform therapeutics
Learn about current strategies to increase drug discovery success

Post conference workshop on 20 March 2019
Artificial Intelligence in Drug Discovery
Led by: Nick Camp, Consultant
WHO SHOULD ATTEND
CEOs, Presidents, Vice Presidents and Global Heads, Executive Directors, Vice President & Global head, Principal Scientists, Heads of Business Development, Directors of Pharma/Biotech firms.
EARLY BIRD-RATES

BOOK BY 30 NOVEMBER AND SAVE £400
BOOK BY 15 DECEMBER AND SAVE £200
BOOK BY 31 JANUARY AND SAVE £100

21st Annual Superbugs & Superdrugs Conference
2019-03-18 - 2019-03-19 | HOLIDAY INN KENSINGTON FORUM, 97 Cromwell Road, London, SW7 4DN, United Kingdom
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections.

SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019. This year’s event aims to provide valuable insights and key updates on the latest developments within the scientific communities, as well as the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections.
The two-day conference will also host a diverse gathering of policy makers and economists, in addition to big pharmas and biotechs, who will discuss incentives, partnerships, regulations and new policies. Industry experts and scientific pioneers are set to present on their research advances and clinical data, as well as alternatives to antibiotics, such as monoclonal antibodies and antimicrobial peptides.
2019 HIGHLIGHTS:

Analyse the current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR
Hear about novel immune-therapeutics to target Gram-negative bacterial infections
Learn about strategies to combat β-lactamases
Evaluate the development of precision antibiotics: Agents designed to meet the demands of stewardship
Explore the role of plasmids in the evolution of antimicrobial resistance

Join us in London next year to explore the challenges and solutions to the growing threat of antibiotic resistance, as well as take part in interactive roundtable discussions with leading organisations. Attendees will also have the exclusive opportunity of networking with an unrivalled gathering of senior experts from Chemical Biology Ventures, University of Oxford, MedImmune, HPRA, GARDP, DNDi, Bioharmony Therapeutics, and many more.
Early Bird Discounts!
Book by November 30th and save £400
Book by December 14th and save £200
Book by January 31st and save £100
For more information and to register online, please visit http://www.superbugssuperdrugs.com/pjwl

2nd Annual Pharma Regulatory Summit 2019
2019-03-14 | Kohinoor Continental Hotel, Mumbai, India, Mumbai, India
Pharma Regulatory Summit is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region. This conference will focus on the new strategies, amendments, innovations, developments in the fields of regulatory affairs, intellectual property and medical devices, which reflects new strategies in the field of regulatory affairs.
SPONSORS:

Exhibitor: Nishith Desai Associates

CONFERENCE REGISTRATION PROCESS:
E-mail – kavitha@virtueinsight.co.in Tel: +9144 24762472

Early Bird Discount Price (Ends 28th January 2019) – (INR 10,000 + GST (18%) per delegate)
Standard Price (From 29th January 2019 Onwards) – (INR 15,000 + GST (18%) per delegate)
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available

Get more from the event, with a broader scope bringing the whole communications value chain together.

Clinical Trial Supply Europe 2019
2019-03-13 - 2019-03-14 | Milan, Italy
This year’s Clinical Trial Supply Europe celebrates its 20th year! As a result of this special occasion we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s incredibly successful conference and are returning with full force to Milan with the aim of supporting trial sponsors and solution providers across Europe to ensure trials are delivered on time, partnerships are improved and supply chain uncertainties are resolved.

We will once again be meeting in Milan, Italy, to discuss, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s largest CTS conference this event promises to be a must attend for the industry!
At each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies, thought leading presentations and engaging panels.
This year we will be looking at issues such as, but not limited to discovering the practical benefits of e-labelling; how this technological innovation can expedite packaging and labelling timelines, ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain and whether blockchain’s time come? Is blockchain a buzzword or an actionable tool for disrupting operations?
With such a packed program you can’t afford to miss out. We look forward to meeting you in Milan so make sure to book your place today!

Temperature Controlled Logistics in Biopharmaceuticals Europe 2019
2019-03-13 - 2019-03-14 | Milan, Italy
Facilitating a platform for the pharmaceutical industry to refine their temperature controlled logistics strategy to ensure an overall successful supply chain

The 15th Annual Temperature Controlled Logistics in Biopharmaceuticals returns to Milan, after an extremely successful 2018 event. The largest European clinical and commercial pharmaceutical supply chain will bring together industry experts to examine the ever changing market and how these new dynamics will impact how the sector operates.
Our 2019 agenda will focus on providing a holistic approach to the pharmaceutical supply chain to ensure the quality, efficacy and safety of your product during temperature controlled shipments.
Avoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions, roundtables, fireside chats and case studies to give rise to innovation solutions to existing challenges.
Key topics for 2019 will include:

Developing risk mitigation management plans
Refining your shipping lines to reduce temperature deviations
Adding metrics whilst comparing air, rail and sea distribution to determine the best transportation method for each product
Separating the hype to give rise to practical tangible solutions of how to incorporate blockchain into your supply chain

Join us in March to be a part of the discussions to refine your temperature controlled logistics strategy. Click here to book your place now

Outsourcing Clinical Trials Israel 2019
2019-03-12 - 2019-03-13 | We are pleased to announce the venue is now confirmed. To request the venue details please contact us at events@arena-international.com
Arena International is thrilled to announce that the fifth Outsourcing in Clinical Trials conference is returning to Tel Aviv, 12th – 13th March, 2019, the only clinical outsourcing platform for biotech, pharmaceutical and medical device companies within Israel.
As with its reputation, this conference addresses how companies can effectively develop their outsourcing strategies and attendees with attain an increased understanding of how to enhance their operational efficiencies to ensure timely and cost-effective clinical studies.
This conference is equally an exclusive place in which delegate will network with industry professionals and service providers, as well as attending insightful lectures from senior representatives from entrepreneurial companies within the Israeli Life Sciences sector.
We invite you to join us in March 2019, register your place today.

CPhI South East Asia 2019
2019-03-12 - 2019-03-14 | Queen Sirikit National Convention Center (QSNCC), 60 New Rachadapisek Road, Klongtoey, Bangkok, 10110, Thailand
CPhI South East Asia will move to Bangkok, Thailand in March 12-14 for the first time. Featuring the co-located with FDF, ICSE, P-MEC, InnoPack, and LABworld South East Asia, CPhI South East Asia 2019 will host more than 6,000 attendees and 270 exhibitors. CPhI South East Asia offers you the chance to do business in a booming and expanding market, meet the movers and shakers of the South East Asian pharma industry and keep up to date with trending news and topics.
Whether you are looking for sourcing new business or getting the latest market insight, this is your ONE-STOP – SHOP pharmaceutical platform in South East Asia.
To learn more about this event, visit www.cphi.com/sea

AsiaTIDES: Oligonucleotide & Peptide Therapeutics
2019-02-26 - 2019-02-28 | Hilton Tokyo Bay Hotel | Tokyo, Japan
AsiaTIDES is the only event in Asia that brings together the science, technologies and partners you need to accelerate your oligonucleotide and peptide molecules to market. Join 300+ scientists and executives at this upcoming meeting featuring keynote speakers from Novo Nordisk A/S, Ionis Pharmaceuticals, Alnylam Pharmaceuticals, and WAVE Life Sciences.

Register now at www.AsiaTIDESEvent.com with code “PHARMJ10” and SAVE 10%.

Global NASH Congress
2019-02-25 - 2019-02-26 | London, United Kingdom, London Heathrow Marriott Hotel, London, United Kingdom
Attracting experts working in all areas of nonalcoholic steatohepatitis, the Global NASH Congress will examine the latest research and development in pathogenesis, diagnosis, and treatment of the disease. An increasing number of people are being diagnosed with the nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year, and the primary method of treatment is weight loss. With no approved medicines on the market, the drug development race is intensifying. The pathogenesis of NASH is still not fully understood, and definitive diagnostic methods are invasive, so development has been slow. There are, however, promising developments in research that will hopefully bolster drug development and other methods of treatment. Examples of such developments include improved in vivo liver models, non-invasive diagnostic biomarkers and a better understanding of the disease’s mechanisms. This year’s congress will focus on these exciting advancements, as well as on the challenges of preclinical and clinical research in NASH. There will also be a session on business development/regulation and a showcase of the most promising therapeutics in development.

CAR-TCR Summit Europe
2019-02-25 - 2019-02-27 | Novotel London West, 1 Shortlands, Hammersmith, London, W6 8DR, United Kingdom
The industry-focused CAR-TCR Summit Europe is dedicated to developing, translating and delivering next generation CAR and TCR therapies for patients in Europe.

Join over 250 of Europe’s leading drug developers to learn about never-before-seen clinical updates and novel technology to improve solid tumour targeting, advance allogeneic therapy development and automate manufacturing processes in order to create a targeted, efficacious and commercially viable cancer therapy.
For more information, visit www.cartcr-europe.com

3rd European Clinical Quality Oversight Forum
2019-02-25 - 2019-02-26 | Hilton London Canary Wharf, South Quay, Marsh Wall, London, E14 9SH, United Kingdom
The European Clinical Quality Oversight Forum in London is the ONLY European event dedicated to risk-based approaches for selecting, managing and monitoring clinical vendors and sites. This interactive event focuses on ensuring trial integrity by effectively assessing, optimising and managing the quality of clinical vendors and sites.

To learn more about this event, visit https://goo.gl/uPWwum

Pharma Packaging and Labeling East Coast 2019
2019-02-20 - 2019-02-21 | Philadelphia, Pennsylvania
Now in its 11th year, Pharma Packaging and Labeling is back to deliver key, actionable insights into very latest regulatory requirements, technological innovations, strategic developments, and how to implement them into your packaging and labeling chain with both maximum efficiency and minimal cost.

With evolving regulations and tougher anti-counterfeiting rules, ensuring patient safety and the right systems are in place is more crucial than ever. Meeting the deadlines and adhering to regulations will not only ensure compliance but will also deliver huge benefits to your business and the industry
With popular demand, the US Drug Enforcement Agency will be back to answer questions on current anti-counterfeit regulations and how this will impact your business. The 2019 speaker line up brings together regulatory bodies and pharma companies including the DSCSA, US Customs & Borders, Pfizer, Merck, Trevena, Biogen, Alkermes and an insight into CMOs including PharmoRx Therapeutics, among many others.
Pharma Packaging and Labeling will bring you everything you need to ensure a successful and compliant implementation for your packaging and labeling. With a more interactive and hands on agenda including panel discussions; roundtables; speed networking; think tanks; mini workshops and more, this event will create an environment where commercial packaging and labeling teams from across all sizes of manufacturer can work together to manage creative, technical, and regulatory demands while ensuring patients are safeguarded at all stages.
For more details, please visit http://www.arena-international.com/pharmapackagingeast/

3rd Annual 3D Cell Culture
2019-02-20 - 2019-02-21 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s 3rd Annual 3D Cell Culture
Delivering updates on the development and application of human organs and tissues in vitro

Proudly sponsored by InoCure & TEDD Competence Centre
CHAIRED BY:
Nicola Valeri, Gastrointestinal Cancer Biology and Genomics Team Leader, The Institute of Cancer Research
Stefan Przyborski, Professor of Cell Technology, University of Durham
Cell Culture in an important tool for research and development within the life science industry. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional cell culture methods. 3D cell culture enables cells to grow and interact with their surroundings in all three dimensions, better mimicking the in-vivo conditions in which the cells are naturally present. This enhances the ability for scientists to study basic biological mechanisms such as cell number monitoring, cell viability, proliferation and morphology. 3D cell cultures also have greater stability and longer life spans.

Researchers globally are realizing the potential of 3D cell culture for various applications, including testing and discovering new drugs to treat cancer, organ-on-chip models to study the human physiology in an organ specific context, and 3D cell printing to produce organ models. Therefore, this market is likely to grow over the next few years and is in fact projected to reach USD 1.7 Million by 2022, growing at a CAGR of 20.3% between 2017-2022. Growth in this market is also driven by global factors such as a need for alternative methods to animal resting, funding from governments and private entities and technological advancements in the field.
At the 3D Cell Culture Conference in February, we will look at the latest developments in the 3D Cell Culture field. Participants will have the opportunity to network with industry experts, gain insight into how the pharmaceutical industry is utilizing 3D Cell Culture technologies to enhance research and development, discuss the potential for novel in-vitro cell culture models to replace animal models, and discover novel 3D cell culture systems, organ-on-chip, 3D imaging of organoids and other technologies in development.
Event Hashtag: #SMi3DCellCulture
FEATURED SPEAKERS INCLUDE:
GUEST SPEAKER:

Bill Mattes, Director, Division of Systems Biology, FDA

SPEAKERS INCLUDE:

Asli Akidil, Cell and Molecular Scientist, AstraZeneca
Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Biosciences
Jason Ekert, Head of Complex In Vitro Models, GSK
Philip Hewitt, UK and Eurotox Registered Toxicologist, Head of Early Investigative Technology, Merck
Stefan Kustermann, Lab Head, Investigative Safety, Roche
Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur

KEY TOPICS FOR 2018 INCLUDE:

Organ-on-chip technologies and their applications in the pharmaceutical industry
Panel discussion on whether 3D Cell Culture will replace animal models
Determining the predictive validity of 3D models and achieving standardization for preclinical testing
Global developments in 3D Cell Culture and how this exponential growth will impact researchers
Several novel techniques for imaging of 3D Cell Cultures
Development of 3D eye models for early assessment of retinal toxicity
Musculoskeletal regeneration harnessing preclinical models for tissue repair

View the full agenda: http://www.3d-cellculture.com/pjwl
WHO SHOULD ATTEND
Biotech / Pharma Companies – Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist
Academia Professor – Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director, Vice President, COO
Organisations / Regulatory – Director, Senior Science Advisor, Scientific Officer
EARLY BIRD-RATES

BOOK BY 31ST OCTOBER AND SAVE £400
BOOK BY 30TH NOVEMBER AND SAVE £200
BOOK BY 14TH DECEMBER AND SAVE £100

7th World CNS Summit
2019-02-19 - 2019-02-21 | Seaport Hotel & World Trade Center, One Seaport Lane, Boston, MA, 02210, United States
The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research.

World CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees, helping to overcome the translational challenges in developing efficacious therapeutics.
Developed in combination with experts from Biogen, Eisai, Merck, AbbVie and other leading organizations, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting.
Following numerous neurodegenerative disease clinical failures, the neurodegenerative disease field requires a refreshed approach towards drug development to drive clinical success.
Now in its 7th successful year, the World CNS Summit challenges traditional thinking to guide drug development of efficacious treatments for neurodegeneration, bringing together over 150+ leading minds in the neurodegenerative space, from academia, pharma, biotech and leading consortia, to provide a unique opportunity to bridge the gap of translational drug development.
To learn more and to register online, visit http://bit.ly/2AfTc9J

Pharma Security Asia 2019
2019-02-19 - 2019-02-20 | Singapore, Singapore
The importance of the pharmaceutical industry in the modern-day Asian society cannot be overstressed especially as there are new diseases springing up from different areas, strengthening the importance of adequate drug research and development activities. However, with the growth of the industry in Asia comes the increase in fake drugs. In recent times, these products are still being produced and passed down to consumers in large quantities amidst the impact of the various counterfeiting hubs that have been seen to operate on a global scale. According to World Health Organization (WHO), about ten to thirty percent of the pharmaceuticals distributed to most third world countries are fake and this industry is growing at an alarming rate, even faster than legitimate pharmaceutical companies raking in about $217 billion yearly in sales.
We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.
Thus, To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Security Asia 2019 – An Anti-Counterfeiting, Drug Serialization and Supply-Chain Security Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.
Social Media:
@corvusglobal
https://www.facebook.com/corvusglobalevents/
https://twitter.com/corvusglobal?lang=en

Outsourcing in Clinical Trials West Coast 2019
2019-02-12 - 2019-02-13 | Hyatt Regency San Francisco Airport Hotel 1333 Bayshore Highway Burlingame 94010
After record-breaking attendance in 2018, Arena International’s flagship Outsourcing in Clinical Trials West Coast conference returns to the Bay Area for its 11th year in February 2019.
With 6 tracks spanning across 2 days, the 2019 event is guaranteed to provide you with practical takeaways to help you accelerate your clinical trial timelines as well as insider knowledge on new innovations and technological advancements in the industry.
Focused on enabling collaboration between the clinical trials community in the Bay Area, the 2019 agenda is jam-packed with interactive sessions such as fireside chats, panel discussions, think-tanks and more. Whether you want to dive into a presentation on digital biomarkers or a panel discussion on measuring the health of your vendor partnerships, there is something for everyone at the upcoming meeting.
Don’t miss out on; join us in Burlingame on 12-13 February by registering your place today!

Outsourcing in Clinical Trials: Medical Devices Europe 2019
2019-02-06 - 2019-02-07 | Hilton Munich Airport Terminalstraße Mitte 20 85356
The 6th annual Outsourcing in Clinical Trials Media Devices Europe Conference returns yet again in 2019!
The event will bring together trial sponsors rom across Europe for 2 days, providing engaging presentations from the biggest names in the sector.
The 2019 programme will feature the latest industry trends and outsourcing challenges for the European medical device and diagnostics community. We’ll be exploring the latest regulatory challenges for medical device manufacturers and the opportunities for greater efficiency in trials.
We look forward to seeing you there!

13th Annual Parallel Trade Conference 2019
2019-02-05 - 2019-02-06 | Holiday Inn, Kensington Forum, 97 Cromwell Road, London, SW7 4DN, United Kingdom
SMi presents its 13th annual Parallel Trade conference, taking place in London on the 5th-6th of February 2019. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

The 2019 event is particularly valuable since Brexit and the news of the UK officially leaving the EU on the 29th of March 2019. As such, the UK will no longer be part of the EU free market; hence, having a significant impact on parallel trade.
Furthermore, the FMD (Falsified Medicines Directive) will be coming into effect in February 2019. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market.

To learn more about this event, and to register online, visit www.parallel-trade.com/PharmaJ

3rd Annual CAR-T Congress EU
2019-01-30 - 2019-01-31 | Millennium Gloucester Hotel, 4-18 Harrington Gardens, Kensington, London, SW7 4LH, United Kingdom
CAR-T cell therapy has shown unparalleled success in haematological malignancies, paving the way for the field of immuno-oncology. In 2017 two therapies achieved FDA approval in the USA, and following recent approval by the EMA, it is a landmark time for the industry.

Despite the huge successes there are still a number of hurdles to overcome before CAR-T can be effective in mainstream oncology beyond haematological malignancies. The European CAR-T Congress’ mission is to address the opportunities and challenges that presently face the CAR-T field, to maximise the potential of this ground-breaking therapy.
Hear first-hand the story behind the successes of Novartis & Kite on their roads to approval. Discover how to improve manufacturing with automation to lower cost and increase the scope and reach of the therapies from innovators such as Torque Therapeutics. Explore the viability of allogeneic CAR-T with Cellectis, Celyad and Servier on their approaches to off-the-shelf products. Atillio Bondanza also shares strategies to improve safety with a better understanding of the underlying mechanisms of toxicity.
20+ industry leaders will be offering insight on:

Solid tumour targeting: overcoming the tumour microenvironment
Multi-specific & dual targeting CARs
Process development, scalability & automation
Allogeneic vs Autologous: the potential of off-the-shelf therapies
Patient access, implementation & regulatory challenges
Advances in gene engineering
Safety and toxicity

There is also a dedicated poster session, whereby attendees can showcase their latest research to the CAR-T community, deadline for submissions 14th December 2018.
Save up to £300 by booking on the early bird rate before Friday 30th November 2018. 2019 is going to be a big year for CAR-T in Europe, don’t be the one to miss out on the latest developments.
To learn more about this event, and to register online, visit www.car-tcongresseu.com

3rd Microbiome Movement – Drug Development Europe
2019-01-28 - 2019-01-30 | Novotel Paris Est, Paris, France
Recent breakthroughs in DNA sequencing, metagenomic analysis and computational techniques have given scientists new insight into the structure and function of the human microbiota, an interconnected community of symbiotic, commensal and pathogenic microorganisms. As valuable clinical data solidifies the importance of the human microbiome on human health and disease, recent efforts have sought to harness this research to create microbiome-based therapeutics.

Situated at the heart of therapeutic R&D, the Microbiome Movement – Drug Development Summit kick starts 2019, once again to help large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.
Set to tackle the greatest scientific, regulatory, clinical, manufacturing and commercialisation challenges across the entire drug development value chain, this meeting will showcase leading industry case studies focused on enhancing the application of novel technologies to standardise results, accelerate target discovery and optimise the translation of microbiome research into safe and effective therapeutic products.
View the complete programme here.

SMi’s 8th Annual Pharmaceutical Microbiology
2019-01-21 - 2019-01-22 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s 8th Annual Pharmaceutical Microbiology: Addressing the key challenges, trends and strategies in contamination control
Conference: 21st & 22nd January 2019
Workshop: 23rd January 2019
Location: Copthorne Tara Hotel, London, UK
Website: http://www.pharma-microbiology.com/PharmaJournWL
SPONSORED BY: GOLD SPONSOR: DuPont; SPONSORS: Mettler Toledo, Biomerieux and Copan Group
CHAIRED BY:
James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society
Olivier Chancel, Sterility and Aseptic Process Assurance, Expert, Boehringer Ingelheim

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding. In fact, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022, expanding at a CAGR of 7.3% from 2016 to 2022. This is the 8th year of a conference which is continually run by SMi and which has been very successful over the past few years.
Developing on last years’ success, Pharmaceutical Microbiology UK 2019 will bring together industry experts to discuss and analyse the latest advancement and challenges within pharmaceutical microbiology. Discover how you can keep up with regulatory changes and maintain the utmost efficiency during production and testing.
Event Hashtag: #PharmaMicro
At the 8th Annual Pharmaceutical Microbiology Conference, you will gain insight into:

Challenges in development of a contamination control strategy for different product types
A series of learning experiences within contamination from Boehringer Ingelheim
The use of vaporized hydrogen peroxide bio-decontamination technology in microbiology contamination control
Case studies in deinococcus and fungal and bacterial spores in cleanrooms
Influence of temperature of incubation on results of microbiological environmental monitoring
Risk mitigation strategies for animal-derived raw materials

FEATURED SPEAKERS INCLUDE:

Alexander Stoll, VP Competence Center Microbiology & Aseptic Technique Quality Management, Fresenius Kabi
Di Morris, Senior Manager, Team Leader, Vaccines Quality Audit, GSK
Marine Marius, Scientist, Analytical Research & Development Europe, Sanofi Pasteur
Philippe Dutot, Sterility Assurance Specialist, Novo Nordisk
Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna
Thierry Bonnevay, Microbiology Platform Head, Analytical Research and Development, Sanofi Pasteur
Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

KEY TOPICS FOR 2018 INCLUDE:

Rapid Microbial Methods
Revision of Annex 1 and impact on pharmaceutical microbiology
Contamination control strategies and case studies
Mycoplasma detection, prevention and control
Future of endotoxin testing in pharmaceutical industries
Strengths and weaknesses of vaporized Hydrogen peroxide as a bio-contamination control agent
Mold contamination control
Influence of temperature of incubation on results of microbiological environmental monitoring

WHO SHOULD ATTEND
Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist
EARLY BIRD-RATES

BOOK BY 28TH SEPTEMBER AND SAVE £400
BOOK BY 31ST OCTOBER AND SAVE £200
BOOK BY 30TH NOVEMBER AND SAVE £100

To learn more about this event, and to register online, visit http://www.pharma-microbiology.com/PharmaJournWL

Social Media in the Pharmaceutical Industry
2019-01-21 - 2019-01-22 | Holiday Inn London – Kensington Forum
SMi Group are delighted to present the return of their 11th annual Social Media in the Pharmaceutical Industry conference to London on the 21st– 23rd January 2019.

Social media is the perfect channel for pharmaceutical companies to educate, market, listen and connect with customers, patients and physicians. How the pharmaceutical industry utilize social media is particularly complex as regulators such as the FDA have not yet written the rules about how pharmaceuticals can engage with potential customers and patients.
Join SMi’s 11th annual Social Media in the Pharmaceutical Industry conference to learn the best way your company can benefit froma robust social media strategy. Hear from industry experts on how to leverage social media platforms by keeping the patient at the forefront and exploring the latest advances in digital application such as Artificial Intelligence, challenges and techniques in the field of ‘social pharma’.
How Will You Benefit?
Network and learn from leading professionals such as:

[CHAIR] – Jason Browning, Global Head of Digital Communications & Social Media, Novartis
[CHAIR] – Emma Sutcliffe, Director Patient Engagement and Innovation, NexGen Healthcare Communications
Roeland Van der Heiden, Digital Director, AstraZeneca
Lin Lei, Associate Director Digital Customer Engagement, Teva
Joao Bocas, CEO, DigitalSalutem
Paul Tunnah, CEO, PharmaPhorumMedia
Jacob D Flindt, Founder, pro
Alan Shaw, Director, Strategic Planet; Senior Lecturer: Digital Marketing, Northumbria University
Dennis Fink, Campaign Manager and Social Media Channel Expert, Qiagen
Stefania Alvino, Multichannel Manager, Daiichi Sankyo Co., Ltd.

2019 Featured Highlights:

Explore a result driven, value focused social media strategy in the pharmaceutical industry
Gain insight into procedures and practices required prior to the implementation of social listening
Discuss how to personalise the content relationships with AI
Understand the optimisation of disease awareness through social media channels
Learn how to use social networks and digital communication to engage HCPs
GDPR regulations and limitations to product advertisement (with case studies)
Pharmacovigilance in social media – specifically in adverse events reporting

Check out the brochure online: www.social-media-pharma.com/pj
Early-Bird Rates

REGISTER BY 29TH SEPTEMBER AND SAVE £400
REGISTER BY 31ST OCTOBER AND SAVE £200
REGISTER BY 30TH NOVEMBER AND SAVE £100

Pre-Filled Syringes & Injectable Drug Devices Europe
2019-01-16 - 2019-01-17 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi is proud to present their 11th annual European conference and exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes & Injectable Drug Devices Europe. The event will take place on the 16th-17th of January 2019, in London.

The conference will offer a deep insight into key areas within the field, such as: new technologies and overcoming their hurdles to implementation; connectivity for devices; updates on drug development and the impact on device developments and new regulatory guidelines. Our line-up of expert speakers will enable delegates to learn from market leaders on best practices to overcome common industry hurdles.
Join us in January 2019 to network, benchmark and learn about developments at the forefront of the Pre-Filled Syringes and Injectable Drug Devices industry.
Chairs for 2019:

James Mellman, Device Manager, Novartis
Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT

Featured Speakers:

Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT
Cedric Gysel, Staff Device Engineer, Janssen
Davide Mercadante, Sr Associate Quality Drug Devices, Biogen
Elise Legendre, Head of Late stage PFS Development, Sanofi
James Mellman, Device Manager, Novartis
Joan Malmstrom, Principal Scientist, Novo Nordisk
Justin Wright, Global Head of Innovation, Novartis
Maggie Reiff, Associate Device Engineer, Pfizer
Mathieu Rigollet, Senior PFS Engineer, Roche
Michael Becker, Design Engineer, Boehringer Ingelheim
Reinhard Scheller, Commercial ManagerCyclo Olefin Polymers – COP Europe, Zeon Europe GmbH
Shota Arakawa, Researcher, Mitsubishi Gas Chemical Company
Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS
Steve Chamberlain, Device Engineering Manager, GSK
Suraj Ramachandran, Director, Merck
Vikas Jaitely, Senior Manager Pharmaceutical Sciences & CMC Regulatory Intelligence, Merck

Key Highlights this January:

Engage and interact with like-minded individuals through 5+ hours of dedicated networking time, within the conference programme
Gain insight from fellow field experts through our interactive programme structure and our fantastic delegation with representation from all aspects of the industry, as well as cross-industry thought leaders and decision makers
Discover new technologies being developed to circumvent common industry hurdles and discuss ways in which to overcome the barriers of implementation
Hear case studies about the streamlining of injectable device development – from development to market
Interact with regulatory bodies in order to glean insight into the most recent revisions to regulation and the best ways to integrate them into business practices
Learn about current drug development programmes which will have an imminent impact on the PFS and Injectable devices sector and discuss the influence which drug development has on device development
Discuss patient centricity and the impact of human factors on design processes

View the full agenda online: www.pre-filled-syringes.com/PJ
EARLY-BIRD RATES:

BOOK BY 28TH SEPTEMBER AND SAVE £400
BOOK BY 31ST OCTOBER AND SAVE £200
BOOK BY 30TH NOVEMBER AND SAVE £100

Sponsored by: Mitsubishi Gas Chemical, HarroHoefliger, PHC Corporation, Zwick Testing Machines, Nemera, Schott, Zeon, Fruh ALPHABETICAL ORDER

Myanmar Lab Expo 2018
2018-12-14 - 2018-12-16 | Rose Garden Hotel, Yangon, Myanmar
The most definitive event for Laboratory Industry in Myanmar. Gathering the region’s hospital, Diagnostic, Laboratory, Analytical, Biotechnology and Scientific Instruments & Technology sectors in one convenient location and providing the perfect platform to discover the latest industry innovations, to network and do business.

Myanmar Phar-Med 2018
2018-12-14 - 2018-12-16 | Rose Garden Hotel, Yangon, Myanmar
This is the biggest trade fair for the medical industry in Myanmar, focused on hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors, providing the perfect platform to discover the latest industry innovations, to network and do business.

AI & Big Data for Pharma, part of DATAx
2018-12-12 - 2018-12-13 | New York Hilton Midtown
AI & Big Data for Pharma Summit 2018: Leverage Data Analytics to Deliver Patient-Centric Outcomes

With the race to adopt data and analytics, the pharma ecosystem is transforming to keep up with the rapid pace of change. Unprecedented volumes of real-time data are right at our fingertips, leaders must think strategically about how to gather, harvest, and leverage insights. The is the must-attend event to enhance AI and analytics capability in drug discovery and development, translate patient data into meaningful insights, and master the art of a seamless journey in pharma supply chain and logistics.
Topic Areas Covered Include:

Leveraging real time data in R&D and challenges of unstructured data
Accelerating drug discovery and development through advanced analytics
Streamlining clinical trial efficiency using AI and machine learning
Cultivating industry partnerships to build knowledge networks
The changing face of pharma and how the industry is evolving
Rise of the digital patient: Personalised patient care, precision medicine and AI
Managing demand forecasting, planning, and reduce waste in commercial analytics
Transparency in the global supply chain and optimising robotics and AI

Find out more information and register here: http://bit.ly/2O3MQ1Z

7th Lung Cancer Screening & Continuum of Care
2018-12-12 - 2018-12-13 | Tampa, FL, USA, FL, United States
ACI is excited to announce our 7th Lung Cancer Screening & Continuum of Care Conference on December 12-13, 2018. A dedicated forum to learn and network with representatives from organizations nationwide that are prepared to deliver superior service in thoracic oncology.
Our event will be an exploration of techniques and policy changes to better fit lung screening programs through case studies, research findings and organizational models from renowned healthcare and radiology institutions. The top thoracic oncology programs in the country will showcase their successes and share strategies in achieving excellence in patient care and cost-effective management.

This two-day event will focus on implementing lung screening programs and services to maximize competitive advantage, meet increased demand and exceed patient satisfaction. The goal of this event is to bring industry leaders together, highlight the best practice achievements, and discuss the current issues and developments in imaging services for the thoracic oncology community.
Lung cancer is the leading cause of cancer-related deaths in the United States. This largely stems from lung cancer’s minimal symptoms in its early stages, which is when the disease is most treatable. For this reason, there is a push for regions to offer screening services for their populations, enabling potential patients to receive care at the most opportune time. Providing this service to potential patients comes with its own challenges, such as motivating patients to get screened regularly, generating funding for these services, raising awareness in your community and many more.
